Literature DB >> 9620711

Pneumococcal vaccine: time for another controlled trial.

F Shann1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9620711     DOI： 10.1016/S0140-6736(05)77683-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Non-specific effects of vaccines in developing countries. We need evidence about the effect of vaccines on mortality from all causes.

Authors:  F Shann
Journal:  BMJ       Date:  2000-12-09

2.  Pneumococcal Pneumonia.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

3.  Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine.

Authors:  Anne Balloch; Paul V Licciardi; Fiona M Russell; Edward K Mulholland; Mimi L K Tang
Journal:  J Allergy Clin Immunol       Date:  2010-06-26       Impact factor: 10.793

4.  Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis.

Authors:  C Gilbert; K Robinson; R W Le Page; J M Wells
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 5.  What can children gain from pneumococcal conjugate vaccines?

Authors:  Heikki Peltola; Robert Booy; Heinz-Josef Schmitt
Journal:  Eur J Pediatr       Date:  2004-06-10       Impact factor: 3.183
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.